MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
2.925
+0.105
+3.72%
Opening 09:53 10/05 EDT
OPEN
2.900
PREV CLOSE
2.820
HIGH
2.930
LOW
2.820
VOLUME
6.18K
TURNOVER
--
52 WEEK HIGH
55.60
52 WEEK LOW
2.380
MARKET CAP
2.88M
P/E (TTM)
-0.0426
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XAIR last week (0921-0925)?
Weekly Report · 09/28 10:06
Beyond Air Slips After Disclosure of Long-Term Employment Contract for CEO
Dow Jones · 09/24 21:34
Beyond Air Formalizes CEO Agreement, Boosts CFO Compensation
TipRanks · 09/24 21:04
Beyond Air New US Patent App #20260284331 Published Today For "METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR GROWTH".
Benzinga · 09/24 20:00
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 09/21 21:06
Weekly Report: what happened at XAIR last week (0914-0918)?
Weekly Report · 09/21 10:06
Weekly Report: what happened at XAIR last week (0907-0911)?
Weekly Report · 09/14 10:11
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/11 21:06
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.